Production (Stage)
WELL Health Technologies Corp.
WELL.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.60% | 15.86% | 34.17% | 38.85% | 33.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.60% | 15.86% | 34.17% | 38.85% | 33.14% |
| Cost of Revenue | 29.92% | 35.78% | 51.46% | 62.77% | 51.32% |
| Gross Profit | -3.52% | -5.74% | 16.95% | 16.96% | 16.57% |
| SG&A Expenses | 6.35% | 10.00% | 21.05% | 25.53% | 25.72% |
| Depreciation & Amortization | 16.08% | 17.09% | 16.16% | 15.44% | 9.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.25% | 24.62% | 36.67% | 43.54% | 37.04% |
| Operating Income | -180.30% | -172.02% | -9.33% | -33.18% | -32.84% |
| Income Before Tax | -221.87% | -89.83% | 2,545.93% | 1,247.60% | 429.10% |
| Income Tax Expenses | -9,046.98% | -857.14% | -56.47% | -338.88% | 107.79% |
| Earnings from Continuing Operations | -172.54% | 44.46% | 1,719.96% | 1,487.75% | 281.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 119.70% | 128.35% | -59.46% | -20.40% | 1.07% |
| Net Income | -205.34% | 15,581.62% | 1,042.27% | 3,475.34% | 592.44% |
| EBIT | -180.30% | -172.02% | -9.33% | -33.18% | -32.84% |
| EBITDA | -49.30% | -64.04% | 3.84% | -7.63% | -10.13% |
| EPS Basic | -202.75% | 3,229.63% | 1,081.40% | 3,484.92% | 539.66% |
| Normalized Basic EPS | -90.09% | -186.68% | -118.03% | -117.27% | -95.39% |
| EPS Diluted | -250.28% | 939.71% | 845.31% | 2,548.50% | 516.09% |
| Normalized Diluted EPS | -92.80% | -183.04% | -112.11% | -111.86% | -91.94% |
| Average Basic Shares Outstanding | 1.26% | 1.66% | 4.61% | 4.73% | 5.78% |
| Average Diluted Shares Outstanding | 1.92% | 4.48% | 7.46% | 7.62% | 6.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |